Alpha Teknova, Inc.
TKNODrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How TKNO's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AZD3759 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Frequently asked questions
What is in Alpha Teknova, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Alpha Teknova, Inc.'s (TKNO) pipeline across Phase 2. Its lead program is AZD3759 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alpha Teknova, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Alpha Teknova, Inc. (TKNO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TKNO biotech catalysts?→
Add TKNO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alpha Teknova, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.